Natural compounds which are potential NF-κB inhibitors can selectively induce apoptosis, disrupt cytoskeletal organization, and impair glycogen metabolism in fibrosarcoma cells while sparing normal muscle cells. This evidence concerns the gene NFKB1 and fibrosarcoma.